GDMC secures $28.1m capital from Series A funding

Celadon Partners led the founding round.

SG-based biotech firm Genetic Design and Manufacturing Corporation (GDMC) secured $28.1m (US$21m) from a Series A funding round led by Celadon Partners.

WI Harper Group, SEEDS Capital, and NSG Ventures also participated in the funding round.

GDMC said it plans to use the funds to promote novel technology and process efficiency improvements to drive greater manufacturing cost reductions for partners aiming to advance medicines through clinical trials and towards commercialisation.

The biotech firm is currently constructing a 155,000 sq ft pre-clinical, clinical, and commercial facility supporting Cell, Gene, and Nucleic Acid Therapies (CGNT).

GDMC has already signed their first clients and is taking reservations for the clinical and commercial facilities expected to open in a staggered format from 2024 to 2027.

Follow the link s for more news on

biotechnology

Singapore Startups

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia